Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03826264 · ClinicalTrials.gov registry record
Transpacific TAVR Registry
A clinical trial of Heart Valve Diseases and Aortic Valve Insufficiency, sponsored by Duk-Woo Park, MD.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 7
- Study locations
NCT03826264: Recruiting study of Heart Valve Diseases and Aortic Valve Insufficiency, sponsored by Duk-Woo Park, MD.
NCT03826264 is a study of Heart Valve Diseases and Aortic Valve Insufficiency that is actively recruiting participants, run by Duk-Woo Park, MD. The registered enrollment target is 10,000 participants, above the 316-participant average among 13 other Heart Valve Diseases trials with a reported enrollment target (3065% higher). The trial reports 7 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03826264, a study of Heart Valve Diseases and Aortic Valve Insufficiency, is actively recruiting participants, sponsored by Duk-Woo Park, MD.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 7
- Study locations
Study Summary
This registry evaluates the long-term outcome of Transcatheter aortic valve replacement (TAVR) in real-world clinical practice.
Conditions Studied
Interventions
- PROCEDURE TAVR
Study Locations (7)
Other
- Second Affiliated Hospital of Zhejiang University - Hangzhou
- Bucheon Sejong Hospital - Bucheon-si
- Chungnam National University Hospital - Daejeon
- Asan Medical Center - Seoul
- Seoul National University Hospital - Seoul
California
- Stanford University - Stanford
Illinois
- Northwestern Memorial Hospital - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2019-06-15 |
| Est. Completion | 2036-12-31 |
What NCT03826264 shows while recruiting
NCT03826264 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 316-participant average among 13 other Heart Valve Diseases trials with a reported enrollment target (3065% higher).
The record links to 2 conditions, with Heart Valve Diseases appearing as the primary indexed condition, and to 1 intervention - of which TAVR is the first listed.
NCT03826264 lists 7 locations in 3 states (Other, California, Illinois).
Frequently Asked Questions
What is clinical trial NCT03826264 about?
NCT03826264 is a clinical study titled "Transpacific TAVR Registry". This registry evaluates the long-term outcome of Transcatheter aortic valve replacement (TAVR) in real-world clinical practice.
What is the current status of trial NCT03826264?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2019-06-15. Estimated completion is 2036-12-31.
What conditions does trial NCT03826264 study?
This clinical trial studies the following conditions: Heart Valve Diseases, Aortic Valve Insufficiency.
What interventions are being tested in trial NCT03826264?
The interventions under investigation include: TAVR (PROCEDURE).
Who is sponsoring clinical trial NCT03826264?
This trial is sponsored by Duk-Woo Park, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03826264 being conducted?
This trial has 7 study locations across California, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Valve Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03826264's enrollment target sits among peer trials
10,000 1st of 13 higher than 13 of 13 other Heart Valve Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Valve Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR
RECRUITING · NA
-
The TRICURE EFS Study
RECRUITING · NA
-
Warfarin Patient Self-management Implementation in the US Healthcare System
RECRUITING · NA
-
EFS of the DUO System for Tricuspid Regurgitation
RECRUITING · NA
-
TRISCEND II Pivotal Trial
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI